Search Results - Bassel F El-Rayes

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer by Gregory B Lesinski, Bassel F El-Rayes, Michael Brandon Ware

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  2. 2

    Advances in Immunotherapy for Hepatocellular Carcinoma (HCC) by Fuat Bicer, Catrina Kure, Anil A. Ozluk, Bassel F. El-Rayes, Mehmet Akce

    Published in Current Oncology (2023-11-01)
    Get full text
    Article


  3. 3

    Comparing VIP and PD‐L1 expression as cancer biomarkers by Jojo Y. Liu, Hanwen Zhang, Sruthi Ravindranathan, Taofeek K. Owonikoko, Bassel F. El‐Rayes, Yuan Liu, Edmund K. Waller

    Published in ImmunoMedicine (2022-12-01)
    Get full text
    Article


  4. 4

    Long -Term Survival in Stage IV Esophageal Adenocarcinoma with Chemoradiation and Serial Endoscopic Cryoablation by Zachary Spiritos, Parit Mekaroonkamol, Bassel F. El-Rayes, Seth D. Force, Steven A. Keilin, Qiang Cai, Field F. Willingham

    Published in Clinical Endoscopy (2017-09-01)
    Get full text
    Article


  5. 5

    Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer by Mohammad Mobayed, Lance K. Heilbrun, Anthony F. Shields, Tara Washington, Raghu Venkatramanamoorthy, Philip A. Philip, Bassel F. El-Rayes

    Published in Case Reports in Oncology (2009-11-01)
    Get full text
    Article


  6. 6

    Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer by Gregory B Lesinski, Christina Wu, Mehmet Akce, Brian Olson, Maria Diab, Batoul Farran, Jeffrey M Switchenko, Manali Rupji, Sandra Kang, Lana Khalil, Amanda Ruggieri-Joyce, Walid L Shaib, Olatunji B Alese, Bassel F El-Rayes

    Published in Journal for ImmunoTherapy of Cancer (2023-10-01)
    Get full text
    Article


  7. 7

    XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial by Maggie J. Phillips, Olatunji B. Alese, Natalie K. Horvat, Emily Greene, Olumide B. Gbolahan, Kathleen Coleman, Deon B. Doxie, Vaunita Parihar, Zaid K. Mahdi, Ashley McCook-Veal, Jeffrey M. Switchenko, Maria Diab, Cameron J. Herting, Chrystal M. Paulos, Bassel F. El-Rayes, Gregory B. Lesinski

    Published in OncoImmunology (2025-12-01)
    Get full text
    Article


  8. 8

    Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma by Sruthi Ravindranathan, Tenzin Passang, Jian-Ming Li, Shuhua Wang, Rohan Dhamsania, Michael Brandon Ware, Mohammad Y. Zaidi, Jingru Zhu, Maria Cardenas, Yuan Liu, Sanjeev Gumber, Brian Robinson, Anish Sen-Majumdar, Hanwen Zhang, Shanmuganathan Chandrakasan, Haydn Kissick, Alan B. Frey, Susan N. Thomas, Bassel F. El-Rayes, Gregory B. Lesinski, Edmund K. Waller

    Published in Nature Communications (2022-10-01)
    Get full text
    Article


  9. 9

    ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma by Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, Julienne L. Carstens, Jeremy B. Foote, Emily C. Graff, Yu-Hua D Fang, Adam B. Keeton, Xi Chen, Jacob Valiyaveettil, Kristy L. Berry, Sejong Bae, Mehmet Akce, Greg Gorman, Karina J. Yoon, Upender Manne, Michael R. Boyd, Donald J. Buchsbaum, Asfar S. Azmi, Yulia Y. Maxuitenko, Gary A. Piazza, Bassel F. El-Rayes

    Published in Molecular Cancer (2025-03-01)
    Get full text
    Article


Search Tools: